PNP Therapeutics, UAB and Southern Research Institute work abolishes otherwise unmanageable human cancers in preclinical rodent studies.
“Complementary and Alternative Therapies: What You (And Your Doctor) Don’t Know Can Hurt You” to be held Jan. 24
Friedman will conduct research on medulloblastoma, the most common malignant brain tumor found in children.
New director to help establish UAB as the South’s leading center for treating leukemia, lymphoma, multiple myeloma and related diseases.
UAB faculty will give 25 presentations at ASCO scientific meeting; topics also include ovarian and breast cancers and AML, or acute myeloid leukemia.
Forero-Torres will be the first holder of a professorship position endowed by the O'Neal-Sokol Breast Cancer Research Foundation of Alabama.
Six UAB teams are finalists in the 2011-12 Alabama Launchpad class.
A drug long used for adults with sickle cell disease could change how the disease is managed in very young children.